Telomere shortening in type II pneumocytes relates to idiopathic pulmonary fibrosis

Aernoud van Batenburg (Nieuwegein, Netherlands), Aernoud van Batenburg, Reinier Snetselaar, Roel Goldschmeding, Jan Grutters, Karin Kazemier, Coline van Moorsel

Source: International Congress 2016 – New findings in mucosal immunology
Session: New findings in mucosal immunology
Session type: Poster Discussion
Number: 1825
Disease area: Interstitial lung diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Aernoud van Batenburg (Nieuwegein, Netherlands), Aernoud van Batenburg, Reinier Snetselaar, Roel Goldschmeding, Jan Grutters, Karin Kazemier, Coline van Moorsel. Telomere shortening in type II pneumocytes relates to idiopathic pulmonary fibrosis. Eur Respir J 2016; 48: Suppl. 60, 1825

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Ex vivo trans-differentiation of primary human alveolar epithelial cells type II by TGFb
Source: International Congress 2014 – ILDs: pathogenesis and clinical features
Year: 2014

Alveolar type II cells transplantation decrease fibrocyte migration in pulmonary fibrosis
Source: Annual Congress 2013 –Novel mechanisms in lung injury
Year: 2013


Pulmonary fibroblasts are affected by notch ligands in vitro
Source: International Congress 2015 – Airway remodelling: recent developments
Year: 2015

Metabolic shift during TGF- β-induced collagen synthesis
Source: International Congress 2016 – IPF pathogenesis
Year: 2016

Unravelling the progressive pathophysiology of idiopathic pulmonary fibrosis
Source: Eur Respir Rev 2012; 21: 152-160
Year: 2012



Parenchymal cell populations involved in the development of fibrosis
Source: International Congress 2014 – ILDs 4
Year: 2014

Thyroid hormone inhibits pulmonary fibrosis through enhancement of mitochondrial function in alveolar epithelial cells
Source: International Congress 2016 – IPF: from pathogenesis to treatment I
Year: 2016


Identification of novel proteins involved in beta-catenin dependent alveolar epithelial trans-differentiation
Source: International Congress 2014 – New and old players in fibrotic lung disease
Year: 2014

A potential role for endothelial adhesion molecules and cytokines in chemotherapy-induced lung fibrosis
Source: International Congress 2014 – Cell biology 2014
Year: 2014


Does apoptosis evasion only affect fibroblasts from idiopathic pulmonary fibrosis?
Source: Annual Congress 2013 –Cell signalling and inflammation: what's new in 2013?
Year: 2013

Distinct gene expression profiles of cultured stromal cells from the patients with idiopathic pulmonary fibrosis and lung adenocarcinoma
Source: International Congress 2015 – Translational studies in airway cell biology
Year: 2015

Mast cells and fibroblasts work in concert to aggravate pulmonary fibrosis: Role of transmembrane SCF and PAR-2/PKCalpha/Raf-1/p44/42 signaling pathway
Source: Annual Congress 2013 –Idiopathic pulmonary fibrosis and rarities
Year: 2013

MiR-31 regulates IRF-1 function in cystic fibrosis epithelial cells
Source: International Congress 2014 – Novel epigenetic regulators for targeting via nanomedicine
Year: 2014

Regulation and role of notch signaling in epithelial progenitor cell differentiation and proliferation in the normal and the fibrotic lung
Source: Annual Congress 2013 –Idiopathic pulmonary fibrosis: pathogenesis
Year: 2013

Proteasome function in lung fibrosis
Source: Annual Congress 2013 –Growth factors at the crossroads of acute and chronic inflammation
Year: 2013

Inhibition of collagen cross-links by novel LOXL2 selective inhibitors in an in-vitro model of fibroblastic foci of IPF
Source: International Congress 2016 – Common mechanisms in lung development and fibrosis
Year: 2016

Fibroblasts from IPF explanted lungs have mitochondrial dysfunction and short telomeres leading to an increased senescence phenotype
Source: International Congress 2016 – IPF: from pathogenesis to treatment I
Year: 2016


Fibroblast growth factor 9 (FGF9) modulates the phenotype of control and fibrotic human lung fibroblasts in vitro
Source: International Congress 2014 – New and old players in fibrotic lung disease
Year: 2014

Epithelial mesenchymal transition in fibroblastic foci of different fibrosing lung diseases: Repair or remodeling?
Source: Annual Congress 2013 –Idiopathic pulmonary fibrosis: pathogenesis
Year: 2013

Role of MUC1 in idiopathic pulmonary fibrosis
Source: International Congress 2016 – ILD pathogenesis
Year: 2016